Sigma Healthcare share price higher despite FY 2020 guidance downgrade

The Sigma Healthcare Ltd (ASX:SIG) share price is charging higher on Friday despite downgrading its earnings guidance for FY 2020…

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In morning trade the Sigma Healthcare Ltd (ASX: SIG) share price has charged higher following the release of a market update.

At the time of writing the pharmacy chain operator and distributor's shares are up 6% to 67.5 cents.

What was in the Sigma market update?

This morning Sigma released an update to its FY 2020 guidance in response to November 25's first-line agreement with the My Chemist/Chemist Warehouse Group (MC/CW Group).

That agreement was for the supply of FMCG products and was effective from December 1. Though, the progressive build-up of supply means it isn't expected to reach a full run rate until July 2020.

This first-line supply contract is for 4.5 years, with sales in the first full year of operations estimated to be between $700 million to $800 million.

To support the work required, Sigma is reinvesting some of the realised gains from the original exit of MC/CW Group, and has delayed some of the remaining Project Pivot transformation efforts and resulting benefits.

Though, it is worth noting that this does not impact the targeted gains of $100+ million from Project Pivot. Sigma remains confident of delivering on this following the actions already taken. Furthermore, around 55% of these realisable benefits have already been delivered.

FY 2020 guidance.

Whilst Sigma's core business continues to perform ahead of expectations, this reinvestment and the delay in the remaining Project Pivot work streams, means that FY 2020 EBITDA is now expected to be $46 million to $47 million. (Or $57 million to $58 million including the benefit from the adoption of the new accounting standard AASB 16 Leases).

This compares to its previous guidance range of $55 million to $60 million.

However, its growth is expected to accelerate in FY 2021. Management will provide its guidance for the next financial year when it releases its full year results in March.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »

Father in the ocean with his daughters, symbolising passive income.
Dividend Investing

I'd spend $8k on these ASX 200 shares today to target a $6,102 annual passive income

I believe these ASX 200 shares will continue rewarding passive income investors for years to come.

Read more »